AI-generated trading idea · NEUTRAL · ABT, ACN, MDLZ, TME, NKE, ORCL, INTC, AMD, AVGO, MS
Night movers — Jul 16: Earnings beat clashes with AI spending fears in a split session
Abbott's earnings beat and raised guidance powered an 11% rally to lead all gainers, while AI capex slowdown fears drove a broad semiconductor selloff that sent ORCL to a 52-week low and dragged INTC, AMD, and AVGO down alongside it. Morgan Stanley's decline despite a blockbuster 60% profit increase highlights a session where strong results were met with selling pressure across multiple sectors.
Idea
## Session overview
Abbott's earnings beat and raised guidance powered an 11% rally to lead all gainers, while AI capex slowdown fears drove a broad semiconductor selloff that sent ORCL to a 52-week low and dragged INTC, AMD, and AVGO down alongside it. Morgan Stanley's decline despite a blockbuster 60% profit increase highlights a session where strong results were met with selling pressure across multiple sectors.
## Compared with previous session
The prior night's edition saw ORCL as a top gainer at 3.6%, but AI spending fears have since reversed it into tonight's worst loser at minus 6.2%. INTC and AMD both extended their previous-session losses, deepening the semiconductor rout that dominated both nights.
## Gainers
- **ABT +10.71%** — Abbott surged over 10% after posting a second-quarter earnings beat and raising its full-year 2026 profit guidance on improved performance across most business lines. Bloomberg and Yahoo Finance both reported the stronger-than-expected results that propelled shares sharply higher.
- **ACN +5.54%** — No matching ingested catalyst was found for ACN. The move is reported without a news attribution.
- **MDLZ +4.60%** — No matching ingested catalyst was found for MDLZ. The move is reported without a news attribution.
- **TME +4.29%** — No matching ingested catalyst was found for TME. The move is reported without a news attribution.
- **NKE +4.21%** — No matching ingested catalyst was found for NKE. The move is reported without a news attribution.
## Losers
- **ORCL -6.25%** — Oracle slid to a 52-week low amid mounting fears around AI spending sustainability, reversing decisively from its prior-night gainer status. Piper Sandler maintained a Buy rating on the stock even as shares continued to decline.
- **INTC -5.84%** — Intel dropped alongside other semiconductor names as AI capex slowdown fears rippled through the chip sector after Marvell's 8% decline. The selloff extended yesterday's losses for INTC, which had already fallen 4.4% in the previous session.
- **AMD -5.33%** — AMD fell over 5% as fears of an AI capex slowdown weighed on semiconductor stocks broadly following Marvell's steep intraday drop. The decline marks a second consecutive session of losses for the chipmaker after yesterday's 3.5% slide.
- **AVGO -5.03%** — Broadcom slid more than 5% as AI capex slowdown concerns spread through the chip group, dragging the entire semiconductor complex lower. The stock had been a leader in the previous session on reports of a $30 billion supply deal but could not escape the sector-wide pressure.
- **MS -4.45%** — Morgan Stanley declined despite reporting a 60% year-over-year jump in second-quarter profit to $5.6 billion. The pullback suggests investors may have viewed the strong print as already priced in or reacted to broader market headwinds.
Advanced Analysis — institutional-depth research report
Verdict: Wait — the checklist has not confirmed yet
The verdict: wait. The strongest case for this idea is its completed 60-month backtest — a 176.8% total return across 77 trades with a 23.0% maximum drawdown, and win rates that actually improved on shorter windows (63.6% over 12 months) — on names whose recent fundamentals are mostly healthy, like Broadcom's quarter ended May 3, 2026 with 14.9% revenue growth and $10.3B in free cash flow. The strongest case against is that the selling may not be purely sentiment: Oracle closed its May 2026 fiscal year with negative $23.7B of free cash flow and a debt-to-equity ratio of 2.9, Intel booked an $11.0B net loss in the June 2026 quarter, and insider ownership filings for the period ended June 30, 2026 show net open-market selling in every covered ticker (Broadcom insiders sold $283.3M, AMD $153.2M). Nothing fires today — Broadcom is closest, with RSI at 25.9 versus the 35 threshold, but its close sits about $36 below the lower Bollinger band. The evidence would flip to actionable if a name satisfies the full checklist: RSI at or below 35, a close back above the lower Bollinger band, ADX above 20, and the low tagging support while the close holds above it. Until then, the disciplined move is to watch, not buy a falling knife.
Conviction score breakdownComposite score computed by the server from the applicable evidence-tier dimensions.
Measure
Value
Thesis support
60/100
Trade readiness
35/100
Risk quality
55/100
Backtest evidence
72/100
Fundamentals trend
45/100
Score
53/100
Composite Score
53/100
Evidence Tier
backtested
Decision scenariosBull, base, and bear cases synthesized from the cited evidence tier. Likelihoods are rounded evidence-weighted judgments, not statistically calibrated forecasts.
Measure
Value
Evidence Tier
backtested
Trade now — all five entry lists are live but no trigger has fired
Nothing to execute today. The strategy trades oversold long entries in AMD, AVGO, INTC, ORCL and MS, and as of the latest daily close none of the five has satisfied its full entry checklist. AVGO is the closest: its RSI (14) reads 25.9, already below the 35 threshold, and its ADX of 48.4 clears the 20 floor — but the price of $346 sits about $36 below the lower Bollinger band at $382, so the rule set is still waiting for a close back above that band. AMD (RSI 38.0), INTC (RSI 44.1), ORCL (RSI 61.4) and MS (RSI 57.9) are all further from the oversold threshold, and AMD's ADX of 27.2 is the only other trend-strength filter already satisfied.
'Wait' here means monitoring each of the five names daily until RSI (14) closes at or below 35, the close sits above the lower Bollinger band, ADX (14) is above 20, and — on the primary entry rule — the day's low tags the nearest support level while the close holds above it. Note that parameter-sensitivity evaluation exceeded its time budget, so no robust nearby-parameter setup was established; the published thresholds are used as-is. The completed backtest on the lead symbol returned 176.8% over 60 months across 77 trades with a 46.8% win rate and a 23% maximum drawdown — that is the profile of the setup we are waiting on, not a reason to force an early entry.
Risk is defined mechanically: once a position opens, the stop is a 2.4% loss from entry and the hard take-profit is +4.8%, roughly 2-to-1 in the trader's favor, with an additional MACD-histogram exit once RSI recovers above 60. Until an entry fires, the correct position size is zero — chasing a name that is simply below its band, without the oversold reading and support test, breaks the reward:risk the strategy was built on.
ABT price and trigger mapUses the idea timeframe and keeps price levels on the price axis.
Measure
Value
Ticker
ABT
Timeframe
1d
ACN price and trigger mapUses the idea timeframe and keeps price levels on the price axis.
Measure
Value
Ticker
ACN
Timeframe
1d
MDLZ price and trigger mapUses the idea timeframe and keeps price levels on the price axis.
Measure
Value
Ticker
MDLZ
Timeframe
1d
What supports the trade
## Why the bull case still has support The core argument of this idea is that the July 16 session created forced, news-driven dislocations in high-quality franchises, and that a disciplined oversold-recovery entry captures the snapback. The completed backtest gives that argument empirical legs. Over a 60-month daily window the rule set produced a 176.8% total return on 77 completed trades, with a maximum drawdown of 23.0%. The same logic holds up on shorter horizons: 104.4% over 24 months (28 trades, 57.1% win rate, 21.5% max drawdown) and 32.7% over 12 months (11 trades, 63.6% win rate, 16.7% drawdown). The win-rate pattern is the interesting part — the strategy has gotten *more* selective and *more* accurate as the sample narrows, consistent with entries that trigger only when a selloff is structurally contained. The fundamental backdrop gives the entries substance rather than just momentum. Broadcom — the strategy's strongest constituent — posted 14.9% revenue growth in the quarter ended May 3, 2026, with a 69.5% gross margin and 48.6% operating margin, and free cash flow of $10.3B, up 28% sequentially. AMD's June 27, 2026 quarter showed revenue of $11.5B (up 12.5% sequentially) with free cash flow of $4.1B, up 61%. These are not distressed names being bought…
TME Return on equityReturn on equity trend from CommonQuant fundamentals/XBRL data; +2363.6% from first to latest point.
Measure
Value
2016-12-31
0.003974023456431133%
2017-12-31
0.05072491488466394%
2018-12-31
0.0485936215900957%
2019-12-31
0.0913512273457215%
2020-12-31
0.07952914154464542%
2021-12-31
0.060198342508496136%
2022-12-31
0.07644649576914281%
2023-12-31
0.08800329117999535%
2024-12-31
0.09790312836155196%
Latest Value
0.09790312836155196%
Change Pct
2363.577012941784%
Ticker
TME
Timeframe
reported periods
TME Operating marginOperating margin trend from CommonQuant fundamentals/XBRL data; +1198.5% from first to latest point.
Measure
Value
2016-12-31
0.023618436138500343%
2017-12-31
0.1450687551224843%
2018-12-31
0.10740057940479326%
2019-12-31
0.1817252496658017%
2020-12-31
0.16156141734984392%
2021-12-31
0.12162335168352324%
2022-12-31
0.1567804086241575%
2023-12-31
0.2183266070913808%
2024-12-31
0.3066793422766804%
Latest Value
0.3066793422766804%
Change Pct
1198.47438026078%
Ticker
TME
Timeframe
reported periods
ABT sector percentile checkRanks ABT against 757 companies in its sector using CommonQuant fundamentals.